Cardio Diagnostics Holdings, Inc. (CDIO): Nasdaq/NYSE listing notice — Cardio Diagnostics receives Nasdaq minimum bid price deficiency notice

Cardio Diagnostics Holdings, Inc.

Received Nasdaq notice on Sept 21, 2023 for common stock bid price below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until March 19, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
If non-compliant by deadline, may qualify for an additional 180-day period if other listing standards met.
Company considering options including stockholder approval for a reverse stock split to cure deficiency.
Trading of common stock and warrants on Nasdaq continues unaffected during the cure period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cardio Diagnostics Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)

Exact text from the filing

ilure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 21, 2023, Cardio Diagnostics Holdings, Inc. (the “Company”) received a written notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with Nasdaq Listing Rule 5450(a)(2), because the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days (the “Notice”). The Notice has no immediate effect on the listing or trading of the Company’s common stock or warrants on the Nasdaq Capital Market. In accordance w

View on SEC.gov

Browse all listing & compliance notices →

Cardio Diagnostics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001079973-23-001304

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.